Abstract
The purpose of this work is to realize the productive qualities of young pigs by increasing the effectiveness of specific prevention of infectious diseases. The object of the study was 45 pigs of the Landrace breed from 14 to 171 days of age, divided according to the principle of pairs of analogues into 3 groups of 15 heads. The animals of the 1st experimental group were injected with the immunotropic drug PigStim-V in a dose of 1.0 ml per head twice at the age of 14 and 21 days in order to stimulate nonspecific resistance of the body and increase the effectiveness of specific prevention of infectious diseases intramuscularly at the age of 14 and 21 days. Moreover, the second injection was carried out simultaneously with immunization against type 2 porcine circovirus infection. The tested immunotropic drug PigStim-V was administered to animals of the 2nd experimental group once, at a dose of 1.0 ml per head at the age of 21 days simultaneously with a commercial vaccine against porcine circovirus. Animals of the 3rd group served as biological control. The results of the study confirm the effectiveness of the use of the immunotropic drug PigStim-V as an adjuvant in the vaccination of pigs. Both single and double intramuscular injection of PigStim-V increases the titer of specific antibodies against porcine circovirus infection and against α, β and ε toxins of the microorganism Clostridium perfringens, prevents and increases the effectiveness of therapy of diseases of non-infectious etiology, stimulates growth. A more pronounced positive effect is observed with the double administration of an immunotropic drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.